SIMULATIONS PLUS INC (SLP) Stock Fundamental Analysis
USA - NASDAQ:SLP - US8292141053 - Common Stock
17.57 USD
+0.39 (+2.27%)
17.57 USD
0 (0%)
SLP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. SLP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SLP is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year SLP was profitable.
SLP had a positive operating cash flow in the past year.
Each year in the past 5 years SLP has been profitable.
In the past 5 years SLP always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of -47.03%, SLP is not doing good in the industry: 74.29% of the companies in the same industry are doing better.
With a Return On Equity value of -51.05%, SLP perfoms like the industry average, outperforming 45.71% of the companies in the same industry.
SLP's Return On Invested Capital of 3.12% is fine compared to the rest of the industry. SLP outperforms 77.14% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SLP is below the industry average of 6.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.03% | ||
| ROE | -51.05% | ||
| ROIC | 3.12% |
ROA(3y)5.68%
ROA(5y)5.6%
ROE(3y)6.11%
ROE(5y)6.04%
ROIC(3y)4.57%
ROIC(5y)5.03%
1.3 Margins
In the last couple of years the Profit Margin of SLP has declined.
The Operating Margin of SLP (5.82%) is better than 71.43% of its industry peers.
In the last couple of years the Operating Margin of SLP has declined.
Looking at the Gross Margin, with a value of 53.75%, SLP is in line with its industry, outperforming 42.86% of the companies in the same industry.
SLP's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.82% | ||
| PM (TTM) | N/A | ||
| GM | 53.75% |
OM growth 3Y-28.77%
OM growth 5Y-22.51%
PM growth 3Y-12.26%
PM growth 5Y-10.86%
GM growth 3Y-7.23%
GM growth 5Y-3.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SLP is destroying value.
The number of shares outstanding for SLP has been increased compared to 1 year ago.
The number of shares outstanding for SLP has been increased compared to 5 years ago.
SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
SLP has an Altman-Z score of 20.34. This indicates that SLP is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 20.34, SLP belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 20.34 |
ROIC/WACC0.3
WACC10.25%
2.3 Liquidity
A Current Ratio of 5.11 indicates that SLP has no problem at all paying its short term obligations.
SLP's Current ratio of 5.11 is amongst the best of the industry. SLP outperforms 88.57% of its industry peers.
A Quick Ratio of 5.11 indicates that SLP has no problem at all paying its short term obligations.
The Quick ratio of SLP (5.11) is better than 88.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.11 | ||
| Quick Ratio | 5.11 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 38.30% over the past year.
The Earnings Per Share has been growing slightly by 0.41% on average over the past years.
SLP shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.01%.
SLP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.56% yearly.
EPS 1Y (TTM)38.3%
EPS 3Y2.13%
EPS 5Y0.41%
EPS Q2Q%200%
Revenue 1Y (TTM)20.01%
Revenue growth 3Y14.64%
Revenue growth 5Y15.56%
Sales Q2Q%9.81%
3.2 Future
Based on estimates for the next years, SLP will show a very strong growth in Earnings Per Share. The EPS will grow by 21.41% on average per year.
SLP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.40% yearly.
EPS Next Y-764.23%
EPS Next 2Y-8.92%
EPS Next 3Y-1.05%
EPS Next 5Y21.41%
Revenue Next Year10.93%
Revenue Next 2Y6.11%
Revenue Next 3Y6.38%
Revenue Next 5Y9.4%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 27.03, the valuation of SLP can be described as expensive.
Based on the Price/Earnings ratio, SLP is valued cheaply inside the industry as 82.86% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.35, SLP is valued at the same level.
A Price/Forward Earnings ratio of 43.22 indicates a quite expensive valuation of SLP.
The rest of the industry has a similar Price/Forward Earnings ratio as SLP.
SLP's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 33.72.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.03 | ||
| Fwd PE | 43.22 |
4.2 Price Multiples
SLP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SLP is cheaper than 71.43% of the companies in the same industry.
68.57% of the companies in the same industry are more expensive than SLP, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.53 | ||
| EV/EBITDA | 22.98 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)65.41
EPS Next 2Y-8.92%
EPS Next 3Y-1.05%
5. Dividend
5.1 Amount
With a yearly dividend of 0.61%, SLP is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.69, SLP pays a better dividend. On top of this SLP pays more dividend than 94.29% of the companies listed in the same industry.
With a Dividend Yield of 0.61, SLP pays less dividend than the S&P500 average, which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
5.2 History
The dividend of SLP has a limited annual growth rate of 0.01%.
SLP has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.01%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
SLP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of SLP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-1.9%
EPS Next 2Y-8.92%
EPS Next 3Y-1.05%
17.57
+0.39 (+2.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners86.07%
Inst Owner Change-7.44%
Ins Owners17.37%
Ins Owner Change-1.17%
Market Cap353.68M
Revenue(TTM)80.38M
Net Income(TTM)-63.19M
Analysts80
Price Target23.46 (33.52%)
Short Float %6.73%
Short Ratio2.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
Yearly Dividend0.24
Dividend Growth(5Y)0.01%
DP-1.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)160.9%
Min EPS beat(2)0.69%
Max EPS beat(2)321.12%
EPS beat(4)2
Avg EPS beat(4)55.29%
Min EPS beat(4)-90.66%
Max EPS beat(4)321.12%
EPS beat(8)3
Avg EPS beat(8)16.77%
EPS beat(12)4
Avg EPS beat(12)5.67%
EPS beat(16)7
Avg EPS beat(16)7.48%
Revenue beat(2)2
Avg Revenue beat(2)0.96%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.3%
Revenue beat(4)2
Avg Revenue beat(4)-1.21%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)1.3%
Revenue beat(8)5
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-0.44%
Revenue beat(16)10
Avg Revenue beat(16)1.72%
PT rev (1m)-9.21%
PT rev (3m)-9.21%
EPS NQ rev (1m)9.09%
EPS NQ rev (3m)9.09%
EPS NY rev (1m)-41.96%
EPS NY rev (3m)-1153.97%
Revenue NQ rev (1m)3.8%
Revenue NQ rev (3m)-4.28%
Revenue NY rev (1m)0.81%
Revenue NY rev (3m)-1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.03 | ||
| Fwd PE | 43.22 | ||
| P/S | 4.4 | ||
| P/FCF | 33.53 | ||
| P/OCF | 24.9 | ||
| P/B | 2.86 | ||
| P/tB | 7.05 | ||
| EV/EBITDA | 22.98 |
EPS(TTM)0.65
EY3.7%
EPS(NY)0.41
Fwd EY2.31%
FCF(TTM)0.52
FCFY2.98%
OCF(TTM)0.71
OCFY4.02%
SpS3.99
BVpS6.15
TBVpS2.49
PEG (NY)N/A
PEG (5Y)65.41
Graham Number9.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.03% | ||
| ROE | -51.05% | ||
| ROCE | 3.77% | ||
| ROIC | 3.12% | ||
| ROICexc | 4.04% | ||
| ROICexgc | 17.48% | ||
| OM | 5.82% | ||
| PM (TTM) | N/A | ||
| GM | 53.75% | ||
| FCFM | 13.12% |
ROA(3y)5.68%
ROA(5y)5.6%
ROE(3y)6.11%
ROE(5y)6.04%
ROIC(3y)4.57%
ROIC(5y)5.03%
ROICexc(3y)12.97%
ROICexc(5y)16.03%
ROICexgc(3y)84.29%
ROICexgc(5y)97.41%
ROCE(3y)5.53%
ROCE(5y)6.08%
ROICexgc growth 3Y-24.94%
ROICexgc growth 5Y-20.15%
ROICexc growth 3Y-47.05%
ROICexc growth 5Y-36.7%
OM growth 3Y-28.77%
OM growth 5Y-22.51%
PM growth 3Y-12.26%
PM growth 5Y-10.86%
GM growth 3Y-7.23%
GM growth 5Y-3.44%
F-Score4
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 40.33% | ||
| Cap/Sales | 4.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 103.33% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.11 | ||
| Quick Ratio | 5.11 | ||
| Altman-Z | 20.34 |
F-Score4
WACC10.25%
ROIC/WACC0.3
Cap/Depr(3y)99.44%
Cap/Depr(5y)102.61%
Cap/Sales(3y)6.89%
Cap/Sales(5y)7.35%
Profit Quality(3y)126.28%
Profit Quality(5y)123.52%
High Growth Momentum
Growth
EPS 1Y (TTM)38.3%
EPS 3Y2.13%
EPS 5Y0.41%
EPS Q2Q%200%
EPS Next Y-764.23%
EPS Next 2Y-8.92%
EPS Next 3Y-1.05%
EPS Next 5Y21.41%
Revenue 1Y (TTM)20.01%
Revenue growth 3Y14.64%
Revenue growth 5Y15.56%
Sales Q2Q%9.81%
Revenue Next Year10.93%
Revenue Next 2Y6.11%
Revenue Next 3Y6.38%
Revenue Next 5Y9.4%
EBIT growth 1Y-33.13%
EBIT growth 3Y-18.34%
EBIT growth 5Y-10.46%
EBIT Next Year145.07%
EBIT Next 3Y49.49%
EBIT Next 5Y49.82%
FCF growth 1Y-52.99%
FCF growth 3Y-14.87%
FCF growth 5Y-1.4%
OCF growth 1Y-46.86%
OCF growth 3Y-11.47%
OCF growth 5Y2.73%
SIMULATIONS PLUS INC / SLP FAQ
What is the ChartMill fundamental rating of SIMULATIONS PLUS INC (SLP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to SLP.
What is the valuation status for SLP stock?
ChartMill assigns a valuation rating of 3 / 10 to SIMULATIONS PLUS INC (SLP). This can be considered as Overvalued.
How profitable is SIMULATIONS PLUS INC (SLP) stock?
SIMULATIONS PLUS INC (SLP) has a profitability rating of 4 / 10.
What are the PE and PB ratios of SIMULATIONS PLUS INC (SLP) stock?
The Price/Earnings (PE) ratio for SIMULATIONS PLUS INC (SLP) is 27.03 and the Price/Book (PB) ratio is 2.86.
Can you provide the dividend sustainability for SLP stock?
The dividend rating of SIMULATIONS PLUS INC (SLP) is 4 / 10 and the dividend payout ratio is -1.9%.